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SUMMARY
CUL7, OBSL1, and CCDC8 genes are mutated in a mutually exclusive manner in 3M and other
growth retardation syndromes. The mechanism underlying the function of the three 3M genes in
development is not known. We found that OBSL1 and CCDC8 form a complex with CUL7 and
regulate the level and centrosomal localization of CUL7, respectively. CUL7 depletion results in
altered microtubule dynamics, prometaphase arrest, tetraploidy and mitotic cell death. These
defects are recaptured in CUL7 mutated 3M cells and can be rescued by wild-type, but not 3M
patients-derived CUL7 mutants. Depletion of either OBSL1 or CCDC8 results in similar defects
and sensitizes cells to microtubule damage as loss of CUL7 function. Microtubule damage reduces
the level of CCDC8 that is required for the centrosomal localization of CUL7. We propose that
CUL7, OBSL1, and CCDC8 proteins form a 3M complex that functions in maintaining
microtubule and genome integrity and normal development.
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To maintain genomic stability, sister chromatids have to be accurately segregated into
daughter cells through mitosis, a short but extremely dynamic phase of the cell cycle. At the
beginning of mitosis, chromatids line up at the midzone of the mitotic spindle and are then
pulled toward opposite poles, leading to generation of daughter cells with identical genetic
material (Walczak et al., 2010). During anaphase, the mitotic spindle rearranges to form a
central spindle, which will be compressed by the contractile ring to form the midbody, a
complex multi-protein structure also crucial for cytokinesis control at telophase (Glotzer,
2009). Cytokinesis failure leads to cell death or causes tetraploidy, believed to induce
aneuploidy and contribute to tumorigenesis (Ganem et al., 2007).
Microtubules are a critical component of both mitosis and cytokinesis by forming the
structure of both the mitotic and central spindles. Microtubules are cylindrical polymers
made of α/β tubulin dimers that are dynamically unstable, making rapid switches between
growth and shrinkage (Kline-Smith and Walczak, 2004; Kueh and Mitchison, 2009). They
thereby guide chromatid alignment at prometaphase and segregation at anaphase and
facilitate cleavage furrow ingression and abscission (Biggins and Walczak, 2003; Somers
and Saint, 2003; Steigemann and Gerlich, 2009). The orderly assembly and disassembly of
the microtubules are tightly regulated by numerous microtubule-associated proteins
(Compton, 2000; Gadde and Heald, 2004; Glotzer, 2009). Defects in microtubule dynamics
impair various cellular events, most notably mitosis. Inappropriate microtubule dynamics
inhibits the alignment of chromosomes on the metaphase plate, leading to the activation of
the spindle assembly checkpoint pathway (SAC) to inhibit the anaphase promoting complex
(APC), thereby stalling mitotic progression to avoid chromatid mis-segregation (Musacchio
and Salmon, 2007).
CUL7 is a member of the cullin family of proteins that function as scaffold proteins for E3
ubiquitin ligases by binding to the small RING finger protein, ROC1 (also known as RBX1),
and substrates or substrate recruiting factors. CUL7 (1698 residues for human protein) is a
large cullin protein and contains multiple functional domains. CUL7 is relatively
evolutionarily young, having emerged as a functional protein after the appearance of
vertebrates (Marin, 2009), localizes predominantly in the cytoplasm and binds to p53
(Andrews et al., 2006; Nikolaev et al., 2003). Deletion of Cul7 in mice leads to intrauterine
growth retardation and perinatal death (Arai et al., 2003). Mutations in the human CUL7
gene are associated with 3M syndrome, named after three French authors, Miller, McKusick
and Malvaux, who first described this heritable dwarfism (Miller et al., 1975). 3M syndrome
is a severe autosomal recessive disorder characterized by short stature (120 – 130 cm for
adults), unusual triangle-shaped facial features with a broad forehead, and widespread
skeletal abnormalities in the neck, chest, shoulder, upper and lower back, fingers and legs
(Huber et al., 2009; Huber et al., 2005; Maksimova et al., 2007). In addition to the skeleton,
3M syndrome also affects other systems, including reducing quantities of male hormones
and increasing the risk of developing bulges in blood vessels. There is currently no treatment
for the disease. Besides CUL7, two additional genes, OBSL1 and CCDC8, have been found
to be mutated in 3M syndrome. These three genes are mutated in a mutually exclusive
manner, with CUL7 being the most frequently mutated (~65%), followed by OBSL1 (~30%)
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and CCDC8 (~5%) (Hanson et al., 2011a; Huber et al., 2011). Most mutations in these three
genes cause truncations or frameshifts, indicating a loss-of-function as the cause of the
disease. The molecular and cellular mechanism underlying the function of CUL7 in
development and the cellular mechanism of 3M syndrome are not known. This study was
directed at resolving these issues, which led to the discovery that these three 3M gene
products form a complex that functions in maintaining microtubule and genome integrity.
RESULTS
CUL7 localizes to the mitotic apparatus and regulates mitosis
To gain insight into the function of CUL7, we knocked down CUL7 using two different
siRNA oligonucleotides, siCUL7-A and siCUL7-B, in U2OS human osteosarcoma cells and
verified CUL7 depletion by direct immunoblot (Figure 1A, right). We found that depletion
of CUL7 by either siRNA resulted in severe defects, including substantially decreased cell
number, an increase in elongated and interconnected cells with two (tetraploidy) or multiple
nuclei (polyploidy), and reduced cell motility as seen from cell clustering (Figure 1A, left).
As these phenotypes are often associated with defects in cell cycle control, we next
evaluated subcellular localization of CUL7 protein and found that a portion of CUL7 was
readily detected on the centrosome and that the centrosomal localization of CUL7 persists
throughout the cell cycle (Figure 1B). This finding suggested a potential function of CUL7
in mitosis and/or cytokinesis control.
To test this notion, we depleted CUL7 using siRNA and stained cells with an antibody
specific to Ser10-phosphorylated histone H3, which correlates with chromosome
condensation. We found that depletion of CUL7 had little effect on DNA condensation or
decondensation (Figures S1A and S1B). However, when mitotic cells at different stages
were quantified, the percentage of prometaphase cells was significantly increased by more
than 60%, from 28.4 ± 3.5% in cells transfected with scrambled siRNA to 46.0 ± 3.0% in
CUL7 depleted cells (p = 0.016, Figure 1C and see also Figure 6 showing a prolonged
prometaphase with CUL7 depleted cells). Furthermore, the percentage of the prometaphase
cells with unaligned chromosomes was increased in CUL7 depleted cells by 4-fold, from
13.3% to 53.3% (n = 60) (Figure 1D). Knockdown of CUL7 caused a slight increase in
anaphase cells with lagging chromosomes (Figure S1C), which seemed to be fixed at
telophase and cytokinesis (Figure S1D). Together, these results indicated that CUL7
depletion delayed mitotic progression due to impaired chromosome congression at
prometaphase and also causes defects in cytokinesis.
CUL7 depletion caused noticeable cytokinesis defects, including elongated daughter cells
with a long intercellular bridge, daughter cell fusion (Figure 1A), and wide spread cell death.
We performed time-lapse imaging analyses to further examine this. U2OS cells treated with
scrambled siRNA completed cytokinesis within about 2 hours, as measured by the time from
forming a clear midbody at telophase to becoming flattened and undergoing daughter cells
separation (Figure 1E and Movie S1). While CUL7 depleted cells formed furrows normally,
they displayed evident cleavage defects in which many daughter cells remained close
together after their DNA were decondensed. Some cells attempted to separate, causing a
long intercellular bridge. A fraction of cells attempted abscission for as long as 5 hours, and
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then died, as assessed by cell blebbing and shrinkage (Figure 1F and Movies S2). Some
interconnected cells even entered the next round of mitosis (Figure 1G and Movie S3).
Taken together, these results demonstrate that CUL7 plays a critical function during both
mitosis and cytokinesis.
CUL7 is essential for normal microtubule dynamics
To explore the cellular mechanism underlying the function of CUL7 in mitotic control, we
determined the effect of CUL7 depletion on the dynamics of microtubule, a cellular
structure whose integrity is critically important for both mitosis and cytokinesis. Compared
to cells transfected with scrambled siRNA, CUL7 depleted cells showed a significantly
altered microtubule network at interphase as determined by both immunostaining of α-
tubulin and imaging of U2OS cells stably expressing α-tubulin fused with enhanced green
fluorescent protein (EGFP-α-tubulin) (Figure 2A). γ-tubulin staining showed that CUL7
depletion did not alter localization of the microtubule organization center (MTOC) (Figure
S2). To further examine microtubule growth, we expressed EGFP tagged End-binding
protein 1 (EB1), a microtubule plus-end tracking protein (+TIP) which when fused with
EGFP generates fluorescent comets from the centrosome and allows the measurement of
nucleation and microtubule dynamics in living cells (Piehl et al., 2004; Tirnauer et al.,
2004). We found that CUL7 depleted U2OS cells showed irregular EB1 trails compared to
control cells (Movies S4 and S5, and Figure 2B), indicating a function of CUL7 in
maintaining microtubule integrity. The velocity of microtubule plus-end movement was also
measured by tracing the position of EGFP-EB1 in the movies, and it was found that CUL7
depletion significantly ?(p-value)? increased microtubule plus-end growth rate (n > 30)
(Figure 2C). Misregulated microtubule dynamics caused by CUL7 depletion could affect
microtubule-kinetochore attachments, leading to the defects in mitotis and cytokinesis.
3M derived mutations in CUL7 disrupt its function in maintaining genome integrity
Germline mutations in the human CUL7 gene were found in patients with 3M syndrome,
Yakut short stature syndromes and gloomy face syndrome (Huber et al., 2005; Maksimova
et al., 2007). To determine whether the development of 3M syndrome is linked to the
function of CUL7 in mitosis and cytokinesis control, we examined the ability of three
missense 3M mutants, P861S, H1464P, Q1469R, and one truncation mutant, E1594fs, that
target the DOC1 or ROC1-binding domains of CUL7 (Figures 3A and3B), in rescuing the
defects in mitotis and cytokinesis caused by CUL7 depletion. Efficient knockdown of
endogenous CUL7 and ectopic expression of wild type and mutant CUL7 were verified by
qRT-PCR and western blot, respectively (Figures S3A and S3B). Knockdown of CUL7
resulted in significant accumulation of tetraploid and polyploid cells from 3% in cells
transfected with scrambled siRNA to 9% in cells transfected with siRNA against CUL7
(Figure 3C). Ectopic expression of wild-type CUL7 effectively rescued the defects in CUL7
depleted cells, reducing the tetraploid/polyploid cells to 5.2%. In contrast, ectopic
expression of none of the four 3M-derived CUL7 mutants were able to rescue the defects
and instead caused an elevation in the percentage of tetraploid and polyploid cells from
12.6% to 14.6%, indicative of a dominant negative effect. Supporting this finding, ectopic
expression of two non-3M mutants of CUL7, one containing a small deletion in the DOC1
domain (CUL7mtDOC1, deleting residues 863 to 869) and one disrupting ROC1 binding
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(CUL7ΔROC1, deleting residues 1,472 to 1,477, Figure S3C), also failed to rescue the mitotic
defects in CUL7 depleted cells and similar to that of 3M-derived mutants, exacerbated the
tetraploidy defects to 13% and 14%, respectively (Figures 3C, S3D and S3E). Thus, both the
DOC1 domain dependent processivity and binding with ROC1 were impaired in 3M patients
and are vital for CUL7 function in regulating cell proliferation and faithful division.
To provide further evidence linking the function of CUL7 in suppressing 3M syndrome and
its function in mitosis, we investigated skin fibroblasts from two 3M patients bearing
V1484GfsX68 (3M-1) and R1445X (3M-2) mutations, respectively. These two lines of 3M
fibroblast cells contained 8.8% and 6.4% of tetraploid cells (n > 500), respectively, which is
significantly ?(p-value)? higher than the percentage of tetraploid cells found in either NHF-1
cells from a normal human foreskin fibroblast cell line at similar passage (2.4%), and WI-38
cells from a normal human lung fibroblast cell line with much higher passage (3.2%) (Figure
3D, left). Confirming this result, FACS analyses showed that these two lines of 3M
fibroblasts contain 6.69% and 3.31% of polyploid cells, significantly ?(p-value)? (4.6- and
2.3-fold, respectively) higher than that seen in either NHF-1 (1.48%) or WI-38 cells (1.42%,
Figure 3E, right). These results suggest that defects in mitotis and cytokinesis caused by the
loss of CUL7 function may contribute to development of 3M syndrome.
The 3M gene products CUL7, OBSL1 and CCDC8 form a complex
Recently, mutually exclusive mutations in OBSL1 and CCDC8 were identified in 3M
patients that do not carry CUL7 mutations (Hanson et al., 2011b; Hanson et al., 2009; Huber
et al., 2010). Obscurin-like 1 (OBSL1) is a large (1896 residues) and putative cytoskeletal
adaptor protein (Geisler et al., 2007), while CCDC8 is a coiled-coil domain containing
protein without clear functions (Morris et al., 2011). Importantly, the mutations in these
three genes occurred in a mutually exclusively manner, strongly suggesting that OBSL1,
CCDC8, and CUL7 work in the same pathway. We first examined the interaction between
OBSL1 and CCDC8 with CUL7 in cells triply transfected with plasmids expressing these
three proteins. Reciprocal IP-western analyses demonstrated that each protein could be
readily detected in the other two immune complexes, indicating these three proteins co-exist
in the same complex (Figure 4A) and supporting the notion that they function on the same
pathway. OBSL1 can also associate with three other known CUL7-interacting proteins, p53
and CUL9 (Figure S4A) and ROC1 (Figure S4B), but only in the presence of CUL7. We
then performed a gel-filtration experiment and found that endogenous CUL7, CCDC8, p53,
and ROC1 partially co-eluted in at least two distinct fractions: one (fractions 24 – 25) is
around 440 kDa and one (fraction 17) is much larger, around 758 kDa (Figure 4B, blotting
OBSL1 was not possible due to the lack of a suitable antibody). To map the OBSL1 and
CCDC8 binding regions in CUL7, full length and various truncation mutants of CUL7 were
ectopically expressed in 293T cells and their bindings with endogenous CCDC8 and co-
expressed OBSL1 were determined by IP-western analysis. We found that OBSL1 binds to
the C-terminal of CUL7, while both the N- and C-terminal of CUL7 could interact with
CCDC8 (Figure S4C). We next performed a subcellular fractionation assay to determine
where 3M proteins interact in the cell. This experiment showed that OBSL1 interacts with
CUL7 and CCDC8 mainly in the cytoplasm (Figure 4C). Finally, to determine if OBSL1
and CCDC8 are also localized to the centrosome like CUL7, centrosomes of U2OS cells
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overexpressed with Myc-OBSL1 were isolated through two steps of ultracentrifugation.
Notably, a portion of OBSL1 and CCDC8 was clearly identified on the centrosome (Figure
4D). Together, these assays demonstrate that three 3M proteins physically interact with each
other and may assemble a potentially very large complex, which we refer to as the 3M
complex (see Discussion), that could contain as many as four additional proteins, CUL9,
p53 and ROC1, as well as FBXW8 (see below).
FBXW8 is in the 3M complex
FBXW8 (also known as FBX29, FBW6) is an F-box protein and the only reported putative
adaptor protein thus far for CUL7. FBXW8 brings SKP1 to CUL7 and forms a potentially
atypical SCF-like E3 complex (Dias et al., 2002). Disruption of Fbxw8, similar to that of
Cul7, causes pre- and post-natal growth retardation and death of two-thirds of embryos in
utero (Tsunematsu et al., 2006; Tsutsumi et al., 2008). In an attempt to search for potential
substrates of CUL7 complexes, we performed a mass spectrometric analysis of an affinity-
purified FBXW8 complexes derived from 293T cells. Although this analysis has not yielded
an obvious substrate that is targeted by FBXW8 to the CUL7 E3 ligase, it has identified
three known FBXW8-interacting proteins (CUL7, CUL1 and SKP1), and OBSL1 and
CCDC8 that were not previously reported to interact with FBXW8 (Figure 4E). This finding
suggests that FBXW8 is a part of the 3M complex.
We confirmed the FBXW8-CCDC8 and FBXW8-OBSL1 interactions by co-
immunoprecipitation assay (Figures 4F and4G). We further characterized the interaction
between OBSL1 and FBXW8 and found that deletion of the F-box in FBXW8 (ΔF, residues
119 to 161), which is required for binding with SKP1, moderately affected the binding of
FBXW8 to OBSL1. Deletion of the first WD40 domain in FBXW8 (ΔWD1, residues 201 to
326), which is required for binding with CUL7, or a linker region (ΔL, residues 162 to 200)
which is required for binding with both CUL1 and CUL7 (Tsunematsu et al., 2006),
significantly compromised the binding with OBSL1 (Figure 4G). These binding assays are
consistent with the idea that FBXW8-OBSL1 interaction is bridged by CUL7.
OBSL1 and CCDC8 are required for maintaining microtubule and genome integrity
The fact that mutation of CUL7, OBSL1 and CCDC8 genes occur in the same disease in a
mutually exclusive manner and that their products form a complex suggests that they
function in the same pathway. To test this notion, we first characterized several siRNA
oligonucleotides against either OBSL1 or CCDC8 and identified two siRNAs targeting each
gene that work efficiently as verified by either qRT-PCR (Figure S5A) or western (Figure
5A). We found that depletion of either gene induced tetraploid and polyploid cells (Figure
5A), from 2.3% in cells transfected with scrambled siRNA oligonucleotides to an average of
9.0% or 11.6% in cells depleted for OBSL1 or CCDC8, respectively, slightly more severe
than that in cells depleted for CUL7 (8.2%, Figure 5B). This result provides a piece of
evidence that these three 3M proteins function in maintaining genome integrity.
To study whether OBSL1 or CCDC8 depletion also affects microtubule dynamics, U2OS
cells depleted for OBSL1 or CCDC8 were treated with nocodazole for 2 hours to
depolymerize microtubules, followed by a washout to allow for microtubule regrowth. Cells
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depleted for OBSL1, like those depleted for CUL7, recovered their microtubules from
nocodazole treatment more quickly than control cells transfected with scrambled siRNA as
assayed by the overall microtubule fiber intensity (Figures 5C). Likewise, cells depleted for
CCDC8 also recovered microtubules from nocodazole toxicity more quickly than control
cells both in interphase (Figure 5D, upper panels) and during mitosis (Figure 5D, lower
panels).
To further demonstrate the function of OBSL1 and CCDC8 in the regulation of microtubule
dynamics, we knocked down the genes for both proteins in U2OS cells stably expressing
EGFP-α-tubulin and found significant alterations of the microtubule network at interphase
to a similar extent as seen in CUL7-depleted cells (Figure 5E). Importantly, double knock
down of CUL7 with either OBSL1 or CCDC8 or triple depletion of all three 3M genes did
not result in a significant further aggravation of the microtubule defects (Figure 5E,
knocking down efficiency was verified in Figures S5B and S5C). Taken together, these
results indicate that the three 3M genes, CUL7, OBSL1 and CCDC8, share a function in the
negative regulation of microtubule dynamics and the maintenance of genome integrity, and
that they most likely act on the same pathway.
Loss of 3M gene function sensitizes cells to microtubule damage
To further investigate the function of CUL7, OBSL1, and CCDC8 in mitotic regulation, we
depleted these proteins in a human lung tumor cell line (NCI-H1155) stably expressing
histone H2B fused with EGFP (H2B-EGFP), which allows for the monitoring of
chromosome dynamics and nuclear morphology in real-time throughout the cell cycle
(Kavallaris, 2010). Cells were exposed to an otherwise innocuous dose of paclitaxel/taxol
(10 nM), an anti-tumor agent that stabilizes microtubules and interferes with the alignment
of chromosomes on the metaphase plate. Cells were monitored by live cell time-lapse
imaging video microscopy and chromosome alignment was assessed by measuring the time
between nuclear envelope breakdown and the onset of anaphase. Depletion of either CUL7
or OBSL1 dramatically delayed mitotic transit time. While control cells transfected with
scrambled siRNA spent an average of 96.9 minutes between prometaphase and metaphase,
this process took 442 minutes and 417 minutes in cells transfected with siRNA against
CUL7 or OBSL1, respectively (Figure 6A, upper panel and Figure S6A). In cells treated with
low dose taxol (10 nM), both CUL7 and OBSL1 depletion greatly delayed chromosome
alignment and increased the transit time between prometaphase and metaphase from an
average of 194 minutes in cells transfected with scrambled siRNA oligos to 969 minutes and
707 minutes, respectively (Figure 6A, lower panel). Most of these cells went through mitosis
erroneously, exiting as dead cells, as a single cell, as cells divided into more than two cells,
or as multinucleated cells (Figure 6B). Consistent with these results, CUL7 or OBSL1
depletion induces mono- and multi-polar mitotic spindles, an effect that is further enhanced
by 1 nM taxol treatment (Figure 6C). Co-depletion of MAD2 completely rescued siCUL7 or
siOBSL1 induced prometaphase delay (Figure 6D and Figure S6C, D), suggesting that
CUL7 or OBSL1 depletion activated the spindle activation checkpoint (SAC). Surprisingly,
depletion of CCDC8 did not generate noticeable phenotypes (Figure S6B). Further study
demonstrated that CCDC8 was expressed at a barely detectable level in NCI-H1155 cells
(Figure S6D), which suggests that CCDC8 may be silenced in these cells and could explain
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why the cells were not responsive to siCCDC8. Together, these results demonstrate similar
functions of CUL7, OBSL1, and CCDC8 in controlling prometaphase and indicate that the
mitotic defects induced by CUL7, OBSL1, or CCDC8 depletion are mediated through a loss
of microtubule integrity.
CCDC8 is required for centrosomal localization of CUL7
To provide further evidence for the functional interaction among 3M proteins, we
investigated the regulatory relationship among them with a focus on CUL7, the only
enzyme-encoding and most frequently mutated gene of the three. Depletion of OBSL1 did
not seem to significantly affect the levels of CCDC8 expression (data not shown), nor did
depletion of CCDC8 affect the levels of CUL7 expression (Figure 5A). There are, however,
two significant impacts on CUL7 upon losing either OBSL1 or CCDC8 function. First,
depletion of OBSL1 in NCI-H1155 cells and U2OS cells substantially reduced the steady
state levels of both CUL7 mRNA and protein (Figures S6A, S7A). This is consistent with a
previous report showing that in a different cell line, HEK293, knocking down OBSL1
reduced both CUL7 mRNA and protein (Hanson et al., 2009). Second, silencing CCDC8,
which did not affect levels of CUL7 expression (Figure 5A), significantly ?(p-value)?
compromised the centrosomal localization of CUL7 in both interphase and mitotic cells
(Figure 7A and S7B). These results suggest that the function of CUL7 is subject to
regulation by the other two 3M proteins, specifically at the level of expression by OBSL1
and centrosomal localization by CCDC8.
Microtubule damage reduces CCDC8 expression and diminishes the centrosomal
localization of CUL7
To further substantiate the regulation of CUL7 by the other 3M proteins, we focused on the
regulation of CUL7 by CCDC8 and examined the impacts of microtubule damage on this
regulation. Treatment of U2OS cells with either nocodazole or taxol had no significant ?(p-
value)? effect on the level of CUL7 expression, but substantially reduced the levels of
CCDC8 expression (Figure 7B). In accordance with CCDC8 reduction, both nocodazole and
taxol treatments diminished centrosomal localization of CUL7 (Figures 7C, S7C). Time
course experiments demonstrated that CCDC8 reduction following microtubule damage was
not an acute effect but instead took more than 8 hours (Figure 7D), which correlated closely
with the loss of centrosomal localization of CUL7 (Figures 7E and S7D). To determine
whether the reduction of CCDC8 and diminished centrosomal localization of CUL7 are
caused by microtubule damage or the cell cycle arrest at mitosis, we synchronized NHF-1
cells at different phases and verified the synchrony by FACS analysis (Figure S7E). Direct
immunoblotting analyses demonstrated that the steady state levels of both CUL7 and
CCDC8, as well as CUL9, remain relatively constant throughout the cell cycle (Figure 7F
and quantification in Figure S7F). Treatment of microtubule-damaged cells with a
proteasome inhibitor did not restore the levels of CCDC8 expression (Figure S7G). Instead,
quantitative PCR analysis demonstrated that CCDC8 mRNA was reduced by microtubule
damage (Figure S7H), suggesting that transcriptional inhibition is a major mechanism for
microtubule damage-induced CCDC8 reduction. While the CCDC8 protein is reduced by
nearly 70% 24 hours after microtubule damage, CCDC8 mRNA was only reduced by about
40%, suggesting an additional posttranscriptional mechanism in the regulation of CCDC8
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level after microtubule damage. Taking these results together, we demonstrated that
microtubule damages affect the function of CUL7 protein, in part, by down regulating the
levels of CCDC8, which leads to the diminished centrosomal localization of CUL7.
DISCUSSION
A cellular mechanism for 3M syndrome and other developmental disorders
In addition to 3M syndrome, CUL7 and OBSL1 mutations were also found in Yakuts
syndrome, le Merrer syndrome (also known as loomy face syndrome) and Silver-Russel
syndromes (SRS) (Akawi et al., 2011; Huber et al., 2005; Maksimova et al., 2007),
expanding the scope of 3M syndrome and linking these rare and different primordial growth
disorders into a potentially single disease with a common underlying molecular and cellular
mechanism. Three lines of evidence reported in this paper led us to propose a mechanism—
regulation of microtubule dynamics and maintenance of genome integrity—whose
disruption underlies the development of 3M syndrome and other related primordial growth
disorders. First, consistent with their mutually exclusive mutation patterns, three 3M
proteins, CUL7, OBSL1 and CCDC8, physically interact with each other and form a joint
complex. Deletion or knockdown of each individual 3M gene resulted in very similar
microtubule, mitotic and cytokinesis defects. Combined depletion of two or three 3M genes
did not synergistically cause any additive effect. Second, fibroblasts derived from CUL7-
mutated 3M patients exhibit similar mitotic defects and polyploidy that can be rescued by
the ectopic expression of wild-type, but not mutant CUL7. Third, among the 3M proteins,
CUL7, is functionally regulated by the other two, OBSL1 and CCDC8, supporting the
notion that the functions of these three genes are integrated into a single biochemical
complex and cellular pathway. Affecting such a fundamental cellular process as controlling
microtubule and genome integrity that is essential to virtually all cells, explains the wide
spread abnormalities in many different cell types and body systems seen in 3M patients.
We therefore suggest that there exists in vivo a distinct protein complex, which we refer to
as the 3M complex, whose functional impairment leads to severe defects in microtubule
dynamics, chromosome segregation, cell survival and organismal growth.
The 3M complex
We have demonstrated in this study that three 3M proteins, CUL7, OBSL1 and CCDC8,
form an integral complex. Given their mutually exclusive mutation pattern, the nearly
complete coverage of 3M syndrome by their combined mutations and the functional
regulation of CUL7 by OBSL1 and CCDC8, we postulate that CUL7, OBSL1 and CCDC8
constitute the core 3M complex. Besides CUL7, OBSL1 and CCDC8, the 3M complex
likely interacts with multiple additional proteins, including notably ROC1—the presumptive
catalytic RING figure protein, FBXW8—a potential substrate adapter, CUL9—a binding
partner and downstream effector of CUL7, and p53—a checkpoint gene whose function has
long been implicated in mitotic control. The exact biochemical function of each of these
four, and possibly other, proteins interacting with 3M complex remains to be determined.
Identification of the function of the 3M genes and complex in the regulation of microtubule
dynamics offers a functional assay for elucidating the physiological significance of the
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interaction between the 3M complex and these proteins. One such example is provided in
the accompanying paper where we showed that CUL9 is a downstream effector of the 3M
complex.
The 3M complex functions in maintaining microtubule integrity
We suggest that a critical function of the 3M complex is to regulate microtubule dynamics,
for example, by controlling the level of a microtubule stabilizer. Previous studies have
suggested a variety of different functions for the 3M proteins. These include a function of
CUL7 in vascular morphogenesis (Arai et al., 2003) and targeting insulin growth factor for
degradation (Xu et al., 2008), a function of OBSL1 in myocyte modeling (Geisler et al.,
2007), in epithelial-mesenchymal transition of choriocarcinoma cells (Fu et al., 2010) and in
Golgi morphology and dendrite patterning (Litterman et al., 2011). Four lines of evidence
support the notion that the severe and broad defects seen in 3M patients and Cul7 mutant
mice can be better explained by an impaired function of the 3M complex in the regulation of
microtubule dynamics.
First, loss of 3M proteins accelerates microtubule growth in both interphase and mitotic
cells, implying a function for the 3M complex in either inhibiting microtubule growth or
promoting microtubule catastrophe. Second, the loss of function of 3M complex proteins
sensitizes cells to the treatment by low dose taxol, which binds to β tubulin in the
microtubules and impairs GTP hydrolysis and the function of microtubules. Third,
fibroblasts derived from 3M patients and cells depleted for individual 3M genes develop
similar aneuploidy, and mitotic and cytokinesis defects, all of which can be caused by a
defect in sensing or repairing microtubule damages. Fourth, we have identified one function
of CCDC8 in localizing CUL7 to centrosome. Furthermore, we showed that treatment of
cells with microtubule damaging agents reduces the cellular levels of CCDC8 and that this
reduction is associated with the loss of centrosomal localization of CUL7. Collectively,
these results not only established a function of 3M proteins and the 3M complex in
maintaining microtubule integrity, but also the regulation of the 3M complex in response to
microtubule damage.
Our study also raises a number of critical questions. How does microtubule damage regulate
the expression of CCDC8 and thus the centrosomal localization of CUL7? How are the
formation of the 3M complex and the association of other proteins with CUL7 regulated?
What is the role of p53, which binds to, but is not degraded by, CUL7 in the 3M complex?
The establishment of the cellular function of the 3M complex in maintaining microtubules
and genome integrity should significantly facilitate the investigation of these and other
questions important for the understanding of this newly discovered 3M complex in mitotic
regulation and development.
EXPERIMENTAL PROCEDURES
Large-scale immunoprecipitation and mass spectrometry
To isolate and identify FBXW8-interacting proteins, retrovirus encoding FLAG-SBP-
FBXW8 was generated and infected into HEK293T cells, followed by puromycin selection
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to make a stable cell line. Two 150mm dishes of cells with around 90% confluence were
collected, and proteins extracted with NP40 buffer. FBXW8 protein complexes were
purified with streptavidin sepharose (GE) and eluted with 50 mM biotin (Sigma), followed
by trypsin digestion and mass spectrometric analysis. For desalting and nano LC-ESI
MS/MS, after digestion, the tryptic peptides were dried and redissolved into 200 μL 5%
acetonitrile (ACN) and 0.5% trifluoroacetic acid (TFA). The peptides were cleaned using a
desalting column (PepClean C18, Pierce) according to the manufacturer's protocol. A minor
modification of the protocol was made to include larger elution volume (200 μL) and
repeated three times in order to increase the peptide recovery. The elution solution was
lyophilized and resuspended into buffer A (2% ACN, 98% water and 0.1% formic acid)
prior to LCMS separation.
For nano-scale reversed-phase liquid chromatography electrospray ionization tandem mass
spectrometry (RPLC-ESI MS/MS) analysis was performed on an Eksigent Ultra-LTQ
Orbitrap Velos system (Thermo Scientific), approximately 3 μL samples were loaded onto
an IntegraFrit column (C18, 75 μm×15 cm, 300 Å, 5 μm, New Objective). A linear gradient
was run from 100% buffer A to 40% buffer B (98% acetonitrile, 2% water and 0.1% formic
acid) for 100 minutes and then went to 80% B in another 10 minutes. The gradient stayed in
80% B for 5 minutes and went back to initial status in another 5 minutes. Eluted peptides
were acquired data-dependently using XCalibur software (version 2.1, Thermo Scientific)
with full ion scan mode over m/z range 300-2,000. The top five parent ions in each MS full
scan were selected for further MS/MS analysis.
For database search, raw files acquired from LTQ Orbitrap were processed through
Proteome Discoverer software (version 1.2, Thermo Scientific) and searched against
UniProKB database (Release 2011_12, 20246 human sequences). Here, the human
sequences were extracted from the complete database using Proteome Discoverer software
with “HUMAN” keyword. Oxidation (M) was set as variable modification. Peptide and
protein tolerance were set to 200 ppm and 0.8 Da, respectively. Only distinct proteins and
peptides containing seven amino acids or longer were accepted in the final result. The decoy
database search option was checked in order to get the approximate false-discovery-rate
(FDR). Only peptide confidence with less than 1% FDR was included.
Gel Filtration
Cell lysates of 293T cells were fractionated using size exclusion chromatography. Lysates,
0.5 ml) were run on Superose 6 10/300 GL (GE Healthcare) using an AKTA Purifier (GE
Healthcare) liquid chromotography system with a flow rate of 0.4 ml/min in buffer
consisting of 50 mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.1% CHAPS, 1mM DTT and 150
mM NaCl. Fractions were collected from 7.2 ml to 17.6 ml and analyzed by western blot
analysis. The approximate molecular weight was calculated after calibration of the column
with Gel Filtration Standards (Bio-Rad).
Centrosome Isolation
Lysates from U2OS cells transfected with myc-OBSL1 were first applied to 20% ficoll
cushion and centrosomes were concentrated in the layer between cushion and lysates after
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ultra-centrifugation. Then centrosomes were collected and applied to a discontinous sucrose
gradient (40%, 50% and 70%). After ultra-centrifugation, gradient was collected from top to
bottom, and samples were subject to WB analysis.
Cellular Fractionation
U2OS cells were collected and cell pellet washed with cold PBS, followed by resuspension
in cold cytosol extraction (CE) buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 200 nM
sucrose, 0.05% Triton X-100n and 1 mM EGTA) plus protease inhibitor cocktails.
Resuspended cells were incubated on ice for 10 min, followed by centrifugation with the
supernatant containing cytosol proteins and the pellet the intact nuclei. The pellet was
washed and then resuspended in CE buffer, and a portion was boiled to get total nuclear
protein fraction (N). The remaining nuclear proteins were sonicated. Both the cytosol
proteins and the sonicated nuclear proteins were centrifuged at top speed for 30 minutes to
obtain the cytosol proteins (C) and nuclear soluble proteins (NS).
Cell Synchronization
Pre-synchronized NHF1 cells at G0 phase were obtained by forcing them to grow over-
confluently for 2 days. The cells were re-plated, and then the cells were collected 8 hours
after re-plating to get G1 cells. To get S, G2 and M phase cells, re-plated cells were treated
with aphidicolin (2ug/ml). Twenty-four hours later, the drug was washed out and the cells
were collected 3 hours post-release (S) or 8 hours post-release (G2). Colcemid (100ng/ml)
was added 8 hours post-release of aphidicolin, and then cells were collected 4 hours later to
obtain M phase cells.
Live-Cell Microscopy
U2OS cells stably expressing GFP-α-tubulin and GFP-ubiquitin were cultured in 35 mm
glass bottom dishes (MatTeK), and transfected with scrambled or CUL7 siRNA. After 48
hours, live-cell microscopy was carried out on the BioStation system (Nikon). Images were
obtained every 5 minutes for 16 hours. U2OS cells transiently expressed with GFP-EB1
were studied with living cells microscopy, and images were obtained every 5 seconds for a
period of 3 minutes. Human lung cancer NCI-H1155 cells stably expressing GFP-Histone
H2B were generated through infecting cells with pCLNCX-GFP-Histone H2B retrovirus.
For imaging, the NCI-H1155-GFP-Histone H2B line was transfected with the indicated
siRNA and plated in a 96-well format followed by carrier or paclitaxel treatment 48 hours
post transfection. At 72 hours post-transfection, imaging began on a BD Pathway 855 bio-
imager using a 20X objective. Images were collected at 14.5 minutes intervals for the next
42 hours. Image sequences were generated using ImageJ. Image sequences were then
evaluated for the indicated parameters manually.
For statistical analysis, all P values were calculated with Student's t-test and P<0.05 was
considered as significant.
Additional details and other experimental procedures used in this paper, including plasmids,
siRNA and primer sequences, antibodies and immunological procedures, cell culture,
transfection, and flow cytometry procedures are available in the Supplemental Information.
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➢ A novel and mammalian specific complex regulating microtubule and cell
division
➢ A mechanism for 3M syndrome and related development disorders
➢ CCDC8 maintains centrosomal localization of CUL7 and is reduced by
microtubule damage
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Figure 1. CUL7 protein localizes to mitotic apparatus and is functionally important for mitosis
(A) U2OS cells were transfected with the indicated siRNA for 3 days. Knockdown
efficiency was verified by western blotting (right panel) and cells were stained with anti-α-
tubulin antibody and DAPI.
(B) U2OS cells were stained with antibodies specific to CUL7, γ-tubulin and DAPI.
(C) U2OS cells transfected with scrambled siRNA or siRNA against CUL7 were stained
with DAPI and mitotic cells (at least 100 cells for each sample) were examined
microscopically. Percentage of cells in each phase was plotted. Bars represent mean of three
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independent experiments, and error bars indicate standard deviation. P values indicate
significant differences to control cells by t-test.
(D) Control or CUL7 depleted cells were stained with DAPI and antibodies to α-tubulin, and
kinetochore protein HEC1. Prometaphase cells with obvious unaligned chromosomes were
scored and plotted.
(E, F, G) U2OS cells were treated with scrambled or CUL7 siRNA for 48 hours. Cells were
observed by time-lapse microscopy. The images are stills of the movies at the indicated time
points. See also Movie S1-3.
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Figure 2. CUL7 regulates microtubule dynamics
(A) U2OS or U2OS/EGFP-α-tubulin cells were treated with scrambled or CUL7 siRNA
(siCUL7-A) for 72 hours. Microtubule organization was visualized by α-tubulin staining or
observing EGFP-α-tubulin in living cells with confocal microscopy. See also Figure S2.
(B, C) U2OS cells were transfected with scrambled or CUL7 siRNA for 24 hours and then
EGFP-EB1. Time-lapse microscopy was performed 24 hours after EGFP-EB1 transfection.
The images represent overlay of twenty consecutive pictures showing microtubules growth
path (B). See also Movie S4, 5. (C) The growing velocity of individual microtubules was
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measured. Error bars indicate standard deviation (n>30). P values indicate significant
differences to control cells by t-test.
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Figure 3. 3M derived mutations in CUL7 disrupt its function in regulating microtubule
dynamics and maintaining genome integrity
(A) Schematic representation of human CUL7 protein. 3M patient derived mutations are
indicated in red. The mutations targeting two functional domains, DOC1 and ROC1 binding,
are also indicated.
(B) 293T cells were cotransfected with plasmids expressing indicated proteins. Two days
after transfection, expression and association between CUL7 with FBXW8, p53 and ROC1
was determined by western or IP-western analyses.
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(C) U2OS cells were transduced with retrovirus encoding siRNA resistant, Myc-tagged
wild-type or various CUL7 mutants. Cells were then transfected with scrambled or CUL7
siRNA, followed by α-tubulin and DAPI staining. Images are representative views of each
sample. Five hundred cells from each group were scored for polyploidy. See also Figure S3.
(D, E) Normal human forehead fibroblasts NHF1, normal human lung fibroblasts WI38, and
skin fibroblasts derived from two 3M patients bearing CUL7 mutations were stained with α-
tubulin (red) and DAPI (blue). Five hundred cells of each group were counted to score
tetraploid cells (D), or stained with Hoechst 33342 and then subjected to FACS analysis to
quantify polyploidy cells (E).
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Figure 4. 3M proteins OBSL1 and CCDC8 interact with CUL7 and FBXW8 and form a large
complex
(A) 293T cells were co-transfected with HA-CUL7, FLAG-CCDC8, and Myc-OBSL1. The
association of the 3 proteins was tested by reciprocal IP/western assay. See also Figure S4A,
B.
(B) Cell lysates from 293T cells were fractionated through gel filtration, and the indicated
proteins were detected by western blot.
(C) 293T cells were overexpressed with Myc-OBSL1, and then the cytosolic (C), nuclear
(N), and nuclear soluble (NS) fractions were prepared. Myc IP was performed in C and NS
fractions, followed by western blot with the indicated antibodies.
(D) U2OS cells were transfected with Myc-OBSL1, and then the centrosomes were
collected through a discontinuous sucrose gradient. The samples were subjected to western
blot with the indicated antibodies.
(E) SBP-FBXW8 proteins complexes were purified and SBP-FBXW8 associated proteins
were identified with mass spectrometry. Numbers of unique peptides identified are listed.
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(F) FBXW8-CCDC8 interaction was detected by co-IP analysis in parental 293T and 293T
cells stably expressing FLAG-FBXW8.
(G) Myc-OBSL1 was co-transfected with wild type FLAG-FBXW8 or its truncated mutants
as indicated in 293T cells, and their interaction was detected by co-IP analysis.
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Figure 5. 3M proteins OBSL1 and CCDC8 are required for maintaining microtubule and
genome integrity
(A, B) U2OS cells were treated with scrambled, CUL7, two different OBSL1 and CCDC8
siRNA oligos, followed by α-tubulin and DAPI staining. Pictures are representative views
of the samples. Arrowheads indicate tetraploidy or polyploidy cells (A). Tetraploid and
polyploid cells of each sample were scored (B). See also Figure S5A
(C) U2OS cells were transfected with siCUL7 or siOBSL1. Seventy-two hours after
transfection, cells were treated with 11μM nocodazole for two hours and then fixed at 0 and
10 min post-nocodazole washout and stained with the indicated antibodies.
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(D) U2OS cells were transfected with siRNA against CCDC8 and then treated as described
in (C). Representative interphase and mitotic cells were shown together with the statistics
for the overall microtubule density. Error bars indicate standard deviation
(E) U2OS/EGFP-α-tubulin cells were transfected with the indicated siRNA oligos, and the
microtubule network was observed with confocal microscopy. See also Figure S5B, C
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Figure 6. Loss of 3M genes function sensitizes cells to microtubule damage
(A, B) Human lung cancer cells NCI-H1155 stably expressing EGFP-Histone H2B were
transfected with the indicated siRNA oligos for 48 hours. The cells were then either
untreated or treated with 10 nM taxol for 24 hours, followed by imaging EGFP-Histone H2B
every 14.5 minutes for 40 hours to trace mitosis. Duration from nuclear envelope break to
anaphase was measured for 50 cells from each sample, and time intervals plotted (A). Cells
exiting mitosis as dead cell, as a single cell, divided into more than 2 cells, or as
multinucleated cells were scored as abnormal mitosis (B). See also Figure S6A
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(C) U2OS/EGFP-α-tubulin cells were transfected with indicated siRNA oligo and then
treated with or without 1nM taxol. Cells with either mono- or multi-polar mitotic spindles
were scored as cells with abnormal mitotic spindle. Error bars indicate standard deviation
(D) CUL7 and OBSL1 depletion induced mitotic defects are SAC dependent. NCI-H1155
stably expressing EGFP-Histone H2B was transfected with the indicated siRNA oligos for
48 hours. The cells were followed by imaging EGFP-Histone H2B every 14.5 minutes for
46 hours to trace mitosis. Duration from nuclear envelope break to anaphase was measured
for 50 cells from each sample, and time intervals plotted. See also Figure S6B-D.
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Figure 7. CCDC8 regulates CUL7 and is inhibited by microtubule damage
(A) U2OS depleted of CUL7, OBSL1, or CCDC8 were stained with the indicated
antibodies, and representative images of the interphase and mitotic cells were shown. See
also Figure S7B
(B) U2OS cells were treated with nocodazole (0.5μg/ml) or taxol (100 nM) for 24h, and the
expression levels of the indicated proteins were determined by western blot.
(C) U2OS cells were treated as described in (B), and then were stained with the indicated
antibodies. See also Figure S7C.
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(D, E) U2OS cells were treated with nocodazole or taxol as indicated, and then CCDC8
protein levels (D) or CUL7 localization (E) was determined. See also Figure S7D.
(F) NHF-1 cells were synchronized into different phases, and then the indicated proteins
were detected by western blot. See also Figure S7E, F.
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